227 related articles for article (PubMed ID: 32516140)
1. ELA/APELA precursor cleaved by furin displays tumor suppressor function in renal cell carcinoma through mTORC1 activation.
Soulet F; Bodineau C; Hooks KB; Descarpentrie J; Alves I; Dubreuil M; Mouchard A; Eugenie M; Hoepffner JL; López JJ; Rosado JA; Soubeyran I; Tomé M; Durán RV; Nikolski M; Villoutreix BO; Evrard S; Siegfried G; Khatib AM
JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32516140
[TBL] [Abstract][Full Text] [Related]
2. ELABELA antagonizes intrarenal renin-angiotensin system to lower blood pressure and protects against renal injury.
Xu C; Wang F; Chen Y; Xie S; Sng D; Reversade B; Yang T
Am J Physiol Renal Physiol; 2020 May; 318(5):F1122-F1135. PubMed ID: 32174138
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of apelin and Elabela in cardiovascular disease.
Gao S; Chen H
Biomed Pharmacother; 2023 Oct; 166():115268. PubMed ID: 37562237
[TBL] [Abstract][Full Text] [Related]
4. ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage.
Sato T; Sato C; Kadowaki A; Watanabe H; Ho L; Ishida J; Yamaguchi T; Kimura A; Fukamizu A; Penninger JM; Reversade B; Ito H; Imai Y; Kuba K
Cardiovasc Res; 2017 Jun; 113(7):760-769. PubMed ID: 28371822
[TBL] [Abstract][Full Text] [Related]
5. ELABELA, as a potential diagnostic biomarker of preeclampsia, regulates abnormally shallow placentation via APJ.
Zhou L; Sun H; Cheng R; Fan X; Lai S; Deng C
Am J Physiol Endocrinol Metab; 2019 May; 316(5):E773-E781. PubMed ID: 30860880
[TBL] [Abstract][Full Text] [Related]
6. Elabela-apelin receptor signaling pathway is functional in mammalian systems.
Wang Z; Yu D; Wang M; Wang Q; Kouznetsova J; Yang R; Qian K; Wu W; Shuldiner A; Sztalryd C; Zou M; Zheng W; Gong DW
Sci Rep; 2015 Feb; 5():8170. PubMed ID: 25639753
[TBL] [Abstract][Full Text] [Related]
7. Apelin and apelin receptor expression in renal cell carcinoma.
Tolkach Y; Ellinger J; Kremer A; Esser L; Müller SC; Stephan C; Jung K; Toma M; Kristiansen G; Hauser S
Br J Cancer; 2019 Mar; 120(6):633-639. PubMed ID: 30783205
[TBL] [Abstract][Full Text] [Related]
8. Apelin inhibition prevents resistance and metastasis associated with anti-angiogenic therapy.
Uribesalgo I; Hoffmann D; Zhang Y; Kavirayani A; Lazovic J; Berta J; Novatchkova M; Pai TP; Wimmer RA; László V; Schramek D; Karim R; Tortola L; Deswal S; Haas L; Zuber J; Szűcs M; Kuba K; Dome B; Cao Y; Haubner BJ; Penninger JM
EMBO Mol Med; 2019 Aug; 11(8):e9266. PubMed ID: 31267692
[TBL] [Abstract][Full Text] [Related]
9. ELABELA Improves Cardio-Renal Outcome in Fatal Experimental Septic Shock.
Coquerel D; Chagnon F; Sainsily X; Dumont L; Murza A; Côté J; Dumaine R; Sarret P; Marsault É; Salvail D; Auger-Messier M; Lesur O
Crit Care Med; 2017 Nov; 45(11):e1139-e1148. PubMed ID: 28777197
[TBL] [Abstract][Full Text] [Related]
10. Apelin receptor (Aplnr) signaling promotes fibroblast migration.
Doğan A
Tissue Cell; 2019 Feb; 56():98-106. PubMed ID: 30736911
[TBL] [Abstract][Full Text] [Related]
11. Apelinergic System Structure and Function.
Shin K; Kenward C; Rainey JK
Compr Physiol; 2017 Dec; 8(1):407-450. PubMed ID: 29357134
[TBL] [Abstract][Full Text] [Related]
12. Apela Regulates Fluid Homeostasis by Binding to the APJ Receptor to Activate Gi Signaling.
Deng C; Chen H; Yang N; Feng Y; Hsueh AJ
J Biol Chem; 2015 Jul; 290(30):18261-8. PubMed ID: 25995451
[TBL] [Abstract][Full Text] [Related]
13. APELA promotes tumour growth and cell migration in ovarian cancer in a p53-dependent manner.
Yi Y; Tsai SH; Cheng JC; Wang EY; Anglesio MS; Cochrane DR; Fuller M; Gibb EA; Wei W; Huntsman DG; Karsan A; Hoodless PA
Gynecol Oncol; 2017 Dec; 147(3):663-671. PubMed ID: 29079036
[TBL] [Abstract][Full Text] [Related]
14. ELABELA Is an Endogenous Growth Factor that Sustains hESC Self-Renewal via the PI3K/AKT Pathway.
Ho L; Tan SY; Wee S; Wu Y; Tan SJ; Ramakrishna NB; Chng SC; Nama S; Szczerbinska I; Chan YS; Avery S; Tsuneyoshi N; Ng HH; Gunaratne J; Dunn NR; Reversade B
Cell Stem Cell; 2015 Oct; 17(4):435-47. PubMed ID: 26387754
[TBL] [Abstract][Full Text] [Related]
15. Loss of Apela Peptide in Mice Causes Low Penetrance Embryonic Lethality and Defects in Early Mesodermal Derivatives.
Freyer L; Hsu CW; Nowotschin S; Pauli A; Ishida J; Kuba K; Fukamizu A; Schier AF; Hoodless PA; Dickinson ME; Hadjantonakis AK
Cell Rep; 2017 Aug; 20(9):2116-2130. PubMed ID: 28854362
[TBL] [Abstract][Full Text] [Related]
16. ELABELA: a hormone essential for heart development signals via the apelin receptor.
Chng SC; Ho L; Tian J; Reversade B
Dev Cell; 2013 Dec; 27(6):672-80. PubMed ID: 24316148
[TBL] [Abstract][Full Text] [Related]
17. The Elabela-APJ axis: a promising therapeutic target for heart failure.
Ma Z; Song JJ; Martin S; Yang XC; Zhong JC
Heart Fail Rev; 2021 Sep; 26(5):1249-1258. PubMed ID: 32314083
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the Apelin/Elabela Receptors (APLNR) in Chickens, Turtles, and Zebrafish: Identification of a Novel Apelin-Specific Receptor in Teleosts.
Zhang J; Zhou Y; Wu C; Wan Y; Fang C; Li J; Fang W; Yi R; Zhu G; Li J; Wang Y
Front Endocrinol (Lausanne); 2018; 9():756. PubMed ID: 30631305
[TBL] [Abstract][Full Text] [Related]
19. Structure-Activity Relationship and Bioactivity of Short Analogues of ELABELA as Agonists of the Apelin Receptor.
Trân K; Murza A; Sainsily X; Delile E; Couvineau P; Côté J; Coquerel D; Peloquin M; Auger-Messier M; Bouvier M; Lesur O; Sarret P; Marsault É
J Med Chem; 2021 Jan; 64(1):602-615. PubMed ID: 33350824
[TBL] [Abstract][Full Text] [Related]
20. Fc-Elabela fusion protein attenuates lipopolysaccharide-induced kidney injury in mice.
Xu F; Zhou H; Wu M; Zhang H; Zhang Y; Zhao Q; Brown R; Gong DW; Miao L
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32808659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
